Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 09:22 am Purchase | 2025-06-30 | 13G | Sage Therapeutics, Inc. SAGE | Madison Avenue Partners LP | 6,077,065 9.700% | 1,156,302 (+23.50%) | Filing History |
| 2025-07-30 5:56 pm Sale | 2025-07-30 | 13D | Sage Therapeutics, Inc. SAGE | BIOGEN INC. BIIB | 0 0.000% | -6,241,473 (Position Closed) | Filing History |
| 2025-07-29 2:32 pm Sale | 2025-06-30 | 13G | Sage Therapeutics, Inc. SAGE | VANGUARD GROUP INC | 3,265,802 5.210% | -1,572,367 (-32.50%) | Filing History |
| 2025-07-21 9:18 pm Unchanged | 2025-07-21 | 13D | Sage Therapeutics, Inc. SAGE | BIOGEN INC. BIIB | 6,241,473 10.000% | 0 (Unchanged) | Filing History |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | Sage Therapeutics, Inc. SAGE | BlackRock Inc. BLK | 4,425,077 7.200% | -965,836 (-17.92%) | Filing History |
| 2025-04-01 5:35 pm Purchase | 2025-03-25 | 13G | Sage Therapeutics, Inc. SAGE | Madison Avenue Partners LP | 4,920,763 8.000% | 4,920,763 (New Position) | Filing History |
| 2025-03-07 10:01 am Sale | 2025-02-28 | 13G | Sage Therapeutics, Inc. SAGE | FMR LLC | 500,915 0.800% | -3,616,090 (-87.83%) | Filing History |
| 2025-03-06 4:28 pm Sale | 2025-02-28 | 13G | Sage Therapeutics, Inc. SAGE | MORGAN STANLEY MS | 1,012,337 1.600% | -3,530,655 (-77.72%) | Filing History |
| 2025-02-14 09:00 am Sale | 2024-12-31 | 13G | Sage Therapeutics, Inc. SAGE | RTW Investments, LP | 3,002,370 4.900% | -2,194,649 (-42.23%) | Filing History |
| 2025-02-12 09:30 am Sale | 2024-12-31 | 13G | Sage Therapeutics, Inc. SAGE | FMR LLC | 4,117,006 6.700% | -1,154,102 (-21.89%) | Filing History |
| 2025-02-05 10:41 am Purchase | 2024-12-31 | 13G | Sage Therapeutics, Inc. SAGE | MORGAN STANLEY MS | 4,542,992 7.400% | 4,542,992 (New Position) | Filing History |
| 2025-01-31 09:55 am Sale | 2024-12-31 | 13G | Sage Therapeutics, Inc. SAGE | VANGUARD GROUP INC | 4,838,169 7.900% | -922,280 (-16.01%) | Filing History |
| 2025-01-17 06:02 am Sale | 2025-01-13 | 13G | Sage Therapeutics, Inc. SAGE | BB BIOTECH AG | 1,178,503 1.900% | -3,282,190 (-73.58%) | Filing History |
| 2025-01-10 5:34 pm Unchanged | 2025-01-10 | 13D | Sage Therapeutics, Inc. SAGE | BIOGEN INC. BIIB | 6,241,473 10.200% | 0 (Unchanged) | Filing History |
| 2024-11-14 6:14 pm Purchase | 2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE | BB BIOTECH AG | 4,460,693 7.300% | 955,693 (+27.27%) | Filing History |
| 2024-11-12 4:56 pm Unchanged | 2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE | VANGUARD GROUP INC | 5,760,449 9.430% | 0 (Unchanged) | Filing History |
| 2024-11-12 10:34 am Sale | 2024-11-08 | 13G | Sage Therapeutics, Inc. SAGE | FMR LLC | 5,271,108 8.634% | -1,031,366 (-16.36%) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE | BlackRock Inc. BLK | 5,390,913 8.800% | 0 (Unchanged) | Filing History |
| 2024-11-04 3:28 pm Unchanged | 2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE | VANGUARD GROUP INC | 5,760,449 9.430% | 0 (Unchanged) | Filing History |
| 2024-11-04 2:10 pm Sale | 2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE | VANGUARD GROUP INC | 5,760,449 9.430% | -542,098 (-8.60%) | Filing History |